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Abstract
Introduction: Children and adolescents with a chronic illness have potential risk factors for vitamin D deficiency. An optimal
vitamin D status might have multiple health effects. This study evaluated vitamin D status and its association with age,
gender, and season in a large cohort of chronically ill Finnish patients at a tertiary pediatric outpatient clinic. A cross-
sectional register-based study was carried out, involving altogether 1351 children (51% boys, age range 0.2–18 years), who
visited the outpatient clinic during 2007–2010 and had their vitamin D status (S-25-OHD) determined. A post-doc analysis
was conducted to identify predisposing and preventing factors for vitamin D deficiency.
Results: Almost half (47%) of the S-25-OHD values were consistent with subnormal vitamin D status (S-25-OHD,50 nmol/L)
while only 12% were .80 nmol/L. Age and season were the most important determinants for S-25-OHD concentration.
Mean S-25-OHD concentration differed between age groups (Kruskal-Wallis; p,0.001), adolescents being at highest risk for
vitamin D insufficiency. Young age and vitamin D supplementation were preventive factors for deficiency, while non-Finnish
ethnic background was a predisposing factor. S-25-OHD showed significant seasonal variation in children older than 6 years.
In the whole cohort, S-25-OHD was on average 13 nmol/L higher in summer than in winter, and the prevalence of vitamin D
deficiency ( = S-25-OHD ,37.5 nmol/l) varied from 11% in summer to 29% in winter.
Conclusions: The finding that almost half of the studied Finnish children with a chronic illness had suboptimal vitamin D
status is alarming. Inferior vitamin D status was noted in adolescents compared with younger children, suggesting that
imbalance between intake and requirement evolves with age. Although less common during summer, subnormal vitamin D
status was still observed in 28% of those evaluated in summer. Clinicians should identify individuals at risk and actively
recommend vitamin D supplementation.
Citation: Holmlund-Suila E, Koskivirta P, Metso T, Andersson S, Ma¨kitie O, et al. (2013) Vitamin D Deficiency in Children with a Chronic Illness–Seasonal and Age-
Related Variations in Serum 25-hydroxy Vitamin D Concentrations. PLoS ONE 8(4): e60856. doi:10.1371/journal.pone.0060856
Editor: Brenda Smith, Oklahoma State University, United States of America
Received July 18, 2012; Accepted March 4, 2013; Published April 9, 2013
Copyright:  2013 Holmlund-Suila et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: The Academy of Finland and Finska La¨karesa¨llskapet have supported the writing of the paper. The funders had no role in study design, data collection
and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: heli.viljakainen@helsinki.fi
. These authors contributed equally to this work.
Introduction
Vitamin D is a key nutrient related to well-being and growth
especially in pediatric population [1]. Today nearly 40 tissues are
characterized as target organs for vitamin D [2]; thus its effects
expand far beyond skeletal homeostasis. Vitamin D deficiency in
infancy increases the risk of upper respiratory tract infections [3]
and poor growth [4], and long-term consequences of vitamin D
deficiency are associated to the development of several chronic
diseases [5,6].
Serum 25-OHD is a reliable marker of vitamin D status. It
combines sources of vitamin D: diet and solar exposure. Highest S-
25-OHD concentrations are noted in farmers and lifeguards with
constantly high UVB exposure [7] while lowest values are
observed in northern latitudes where scarce sunlight is often
accompanied with limited dietary intake of vitamin D. Recently,
three independent expert panels have reviewed the evidence on S-
25-OHD for several outcomes. Lawson Wilkins Pediatric Endo-
crine Society concluded that concentrations below 37.5 nmol/l
are suggestive of vitamin D deficiency and concentrations between
37.5 and 50 nmol/L, suggestive of vitamin D insufficiency in
children [8]. Institute of Medicine (2011) added that concentra-
tions over 50 nmol/l are required for normal function of body
including linear growth and bone mass accrual [9], while for
optimizing long-term health such as prevention of diabetes or
fractures concentrations above 75 nmol/l may be needed accord-
ing to Endocrine Society [10].
Hypovitaminosis D is prevalent in Finnish children [11,12]. In
our recent school-based cohort approximately 70% of Finnish
children had S-25-OHD below 50 nmol/L [13]. Compared with
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apparently healthy subjects, children with chronic illness may have
additional risk factors for vitamin D deficiency; these may be
related to the underlying chronic illness, its treatment or related
factors (e.g. inflammation). However, children with chronic illness
are usually under careful pediatric follow-up and more likely to
have proper vitamin D supplementation. Current study was
carried out firstly to evaluate vitamin D status and its association
with gender, age and season in a large cohort of chronically ill
Finnish children. Secondly, we wanted to define factors that
predispose to or protect from vitamin D deficiency in these
children.
Subjects and Methods
Study Cohort
This study is a register-based cross-sectional study on 1351
children, who visited the pediatric outpatient clinics at the
Childrens Hospital, Helsinki University Central Hospital, during
2007–2010 and had their vitamin D status (S-25-OHD) de-
termined as part of routine follow-up. Helsinki is located in
southern Finland (60#N) and the Childrens Hospital is the largest
pediatric hospital in the country. In the hospital region approx-
imately 10% of inhabitants are of non-Finnish background and
less than 5% are non-Caucasian [14]. Subjects included in this
study had one or several chronic diseases, including asthma,
allergies, gastrointestinal diseases, cancer, renal diseases, diabetes
and other endocrine diseases, chronic inflammatory or infectious
diseases, eating disorders or metabolic bone diseases, for which
they required follow-up at a tertiary centre; hospital inpatients
were not included. S-25-OHD measurements were obtained from
the database of the Hospitals Central Laboratory (HUSLAB,
Hospital District of Helsinki and Uusimaa), where all the samples
had been analysed. S-25-OHD measurements were based on the
judgment of clinician in charge of patient care. Several patients
had repeat measurements during follow-up but only the first
measurement obtained during the study period 2007–2010 was
included in the analyses. Baseline characteristics including age,
gender, date of measurement and other laboratory analyses
obtained during the same visit were available and collected from
the database; no information regarding the patients’ ethnic
background or the underlying clinical condition were available
in the laboratory database.A post-hoc analysis was conducted to
identify predisposing and preventing factors for vitamin D
deficiency. From the initial population (N= 1351) we selected
100 subjects for post-hoc analysis: 50 children with the highest,
and 50 with the lowest S-25-OHD values. The groups are called
HIGH and LOW, respectively. Clinical characteristics including
age, gender, ethnicity, key anthropometry, diagnosis and features
of the underlying illness, date of vitamin D sampling and results of
other blood work obtained during the same visit were collected
from hospital records for each subject. The use of register-based
data and the post-hoc analysis were approved by the Research
Ethics Committee of the Hospital District of Helsinki and
Uusimaa.
Laboratory Measurements
S-25-OHD concentration (S-25-OHD total, S-25-OHD2 and
S-25-OHD3) was analysed by high-performance liquid chroma-
tography (HPLC) [15]. The detection limit is 10 nmol/L and the
laboratory reference range .40 nmol/L for all age groups. Values
below the detection limit (N= 4) were recorded as 5 nmol/L and
included in the analysis. S-25-OHD concentrations were divided
into four categories: ,37.5 nmol/L, 37.5–50.0 nmol/L, 50.1–
80.0 nmol/L and .80.0 nmol/L. S-25-OHD concentrations
below 37.5 nmol/L were considered as indicative of vitamin D
deficiency and 37.5–50.0 nmol/L as indicative of vitamin D
insufficiency [8]. S-25-OHD concentrations between 50.1 to
80.0 nmol/L were considered to be sufficient [9] although some
adult studies report beneficial skeletal effects when S-25-OHD
concentration is above 80.0 nmol/L [10].
PTH was analysed with an immune chemiluminometric
assay. The reference range for children and adults is 8–
73 ng/L. Plasma creatinine (P-Cr) concentration was analysed
by photometric enzymatic assay and reference values are
compatible with the Nordic Reference Interval Project: 8
days-2 years 10–56 mmol/L, 3–5 years 10–48 mmol/L, 6–12
years 10–76 mmol/L, girls 13–16 years 15–90 mmol/L, boys
13–16 years 20–95 mmol/L, girls 17–18 years 40–90 mmol/L
and boys 17–18 years 50–95 mmol/L.
Clinical Data
Height (cm) and weight (kg) were collected from patient records
for the 100 subjects in HIGH and LOW groups. Heights are
reported in standard deviation (SD) units and weights as height-
adjusted values (a percentage of the mean weight in gender- and
height-adjusted reference population), according to the Finnish
standards [16,17]. Body mass index (BMI) was calculated as
[weight/height2] and standardized BMI values were derived
according to WHO standards (http://www.who.int/
childgrowth/standards/en/).
Statistical Analysis
Statistical analyses were carried out with PASW Statistics 18.
Simple linear regression analysis was used to define independent
variables associated with S-25-OHD concentration. After
stratification into age groups we investigated seasonal variation
in S-25-OHD concentration with a generalized linear model
(ANCOVA) adjusting for calendar year. We also analysed age-
related differences with ANCOVA using year and season as
covariates. The four seasons were defined in the following way:
from March to May as ‘‘spring’’, from June to August as
‘‘summer’’, from September to November as ‘‘autumn’’ and
from December to February as ‘‘winter’’. S-25-OHD, P-PTH
and P-Ca were not normally distributed, and nonparametric
Spearmans rho was used to test correlations between variables.
PTH was normally distributed within the reference range (8–
73 ng/L).
In order to exclude patients with high S-25-OHD due to renal
insufficiency and hydroxylation defect we excluded patients
(N= 16) with plasma creatinine concentration exceeding the
upper age-specific reference limit by .20% when assessing
vitamin D status and seasonal variation. Subjects in the final
cohort (N= 1335) were divided into five groups according to age:
0.0–2.0 years (N= 129), 2.1–6.0 years (N= 185), 6.1–10.0 years
(N= 229), 10.1–15.0 years (N= 473) and 15.1–18.0 years
(N= 319) (Table 1). This grouping was regarded appropriate as
the national guidelines recommend daily vitamin D supplemen-
tation to those aged 0–2 years. After age 6 years children start
school and age 10–15 years coincides with fastest pubertal
development.
In post-hoc analysis differences in diagnosis of the underlying
disease, age, ethnic background, anthropometry, use of vitamin D
supplements and the season of blood sampling were studied
between the HIGH and LOW groups. Chi Square test was used to
assess the significance between bivariate or nominal variables,
while independent T test was applied in case of continuous
variables.
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Results
S-25-OHD Concentration
Altogether 1335 patients were included in the study (50.5%
boys). Their mean age was 10.665.2 years (range 0.2–18). The
distributions of S-25-OH measurements according to age group,
season, etc. are presented in Table 1.
Of the patients 47% had vitamin D deficiency or insufficiency.
Altogether 23% of the subjects had S-25-OHD below 37.5 nmol/
L and 24% between 37.5 to 50.0 nmol/L. In contrast, only 12%
had a concentration above 80 nmol/L (Figure 1). Determinants of
S-25-OHD concentration were tested with simple linear re-
gression. Variables included age, year of measurement, season,
and gender. Of these the most powerful predictor was age
(standardized Beta 20.354, p,0.001), year of sampling (stan-
dardized Beta 0.142, p,0.001), and season (standardized Beta
0.122, p,0.001). Because gender was not a statistically significant
predictor (p = 0.165) it was not regarded as a confounder in the
analysis. Further analyses were performed by stratifying for age.
Mean S-25-OHD concentration differed significantly between
age groups (Kruskal-Wallis; p,0.001): the highest concentrations
were seen in the youngest and the lowest values in the oldest age
groups. However, year and season remained confounding factors.
Correspondingly, the prevalence of vitamin D deficiency was
lowest (7%) in the 0–2 year olds and highest (33%) in the age
group of 15.1–18.0 years (Table 2).
Children and adolescents aged from 6 to 18 years showed
a significant seasonal variation in S-25-OHD concentration
(ANCOVA; p,0.001) after adjusting for calendar year, but this
was not seen in younger age groups (Table 3). The highest mean
concentrations of S-25-OHD were measured in the summer and
these were on average 13 nmol/L higher than in the winter and
spring. On the other hand children under 2 years of age and
adolescents 15–18 years had significant variation between years,
when using season as a covariate (ANCOVA; p= 0.001). A
tendency towards higher S-25-OHD concentrations in 2010 than
in other yeas was noted in all age groups. In the whole group
prevalence of vitamin D deficiency and insufficiency varied across
seasons (Chi Square; p= 0.001 and p= 0.044, respectively)
(Table 3). Vitamin D deficiency was most commonly observed
in two oldest age groups during winter and spring when 36% and
45% of adolescent were regarded as vitamin D deficient while least
likely to suffer from deficiency was the youngest age group.
Table 1. Frequency of laboratory measurements in the study
population.
N (total 1335)
Gender boys 674 50.5%
girls 661 49.5%
Age group (years) 0–2.0 129 9.7%
2.1–6.0 185 13.9%
6.1–10.0 229 17.2%
10.1–15.0 473 35.4%
15.1–18.0 319 23.9%
Season* winter 362 27.1%
spring 343 25.7%
summer 241 18.1%
autumn 389 29.1%
Year 2007 452 33.9%
2008 300 22.5%
2009 256 19.2%
2010 327 24.5%
*winter =December to February, spring =March to May, summer = June to
August, autumn=September to November.
doi:10.1371/journal.pone.0060856.t001
Figure 1. The prevalence of deficient, insufficient, sufficient,
and optimal vitamin D status in each age group during 2007–
2010.
doi:10.1371/journal.pone.0060856.g001
Table 2. Prevalence of vitamin D deficiency and insufficiency
according to season*.
Vitamin D deficiency (S-25-OHD ,37.5 nmol/L)
Season
Age
group (y) N Winter Spring Summer Autumn Total P{
0–2.0 129 10% 9% 3% 6% 7% Ns
2.1–6.0 185 8% 12% 10% 6% 9% Ns
6.1–10.0 229 19% 22% 11% 12% 17% Ns
10.1–15.0 473 37% 36% 13% 24% 29% ,0.001
15.1–18.0 319 42% 47% 11% 27% 33% ,0.001
Total 1335 29% 29% 11% 19% 23% ,0.001
Vitamin D insufficiency (S-25-OHD 37.5–50 nmol/L)
Season
Age
group (y)
N Winter Spring Summer Autumn Total P{
0–2.0 129 13% 14% 14% 18% 15% ns
2.1–6.0 185 31% 16% 13% 15% 20% ns
6.1–10.0 229 27% 33% 11% 22% 25% ns
10.1–15.0 473 29% 31% 24% 28% 28% ns
15.1–18.0 319 27% 19% 17% 32% 25% ns
Total 1335 27% 25% 17% 25% 24% 0.044
{Pearson Chi-Square.
*winter =December to February, spring =March to May, summer = June to
August, autumn= September to November.
doi:10.1371/journal.pone.0060856.t002
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PTH
Age was the only significant determinant of PTH concentration
in a simple linear regression when using age, year, season, and
gender as independent variables. Thus, PTH concentration varied
with age (ANOVA; p= 0.005) and showed increasing values with
age (data not shown). Patients with PTH concentration above the
reference range (.73 ng/L) (N= 108) were older than others
(mean age 11.765 years vs. 10.365 years; T-test: p = 0.007).
In the study population S-25-OHD correlated inversely with P-
PTH (Spearman’s r =20.250, p,0.001). The correlation re-
mained the same when only those with PTH within the reference
range (8–73 ng/L) were included (Pearson correlation 20.254,
p,0.001). We observed that children under 10 years had stronger
correlation between PTH and S-25-OHD concentrations than
older children (Figure 2).
Post-hoc Analysis
The groups of LOW and HIGH included altogether 100
children, whose characteristics are presented in Table 4. S-25-OH
levels in the LOW group ranged from 5 nmol/L to 20 nmol/L
and in the HIGH group between 103 nmol/L and 168 nmol/L.
Sex distribution was similar in the groups (p = 0.69).
The subjects in the LOW group were significantly older,
heavier, taller, and had higher BMI than those in the HIGH group
(Table 4). Not only the absolute heights and weights were greater
but also the age- and gender- adjusted heights (20.4 SDS vs.21.5
SDS, p= 0.002) and age-, gender- and height-adjusted weights
(+4.7% vs.24.1%, p= 0.054) were greater in the LOW group. On
the other hand, no difference was observed in standardized BMI
between groups. Number of subjects with standardized BMI,22
or .2 indicating under- or overnutrition, respectively, were
distributed similarly between the groups (p = 0.182).
Season affected the results: altogether 76% of the LOW values
were obtained during winter or spring compared to 38% of the
HIGH group, (p,0.001).
The use of vitamin D supplements (data available for 96
subjects) was fairly common as altogether 55% of the patients used
vitamin D as a supplement; this did not differ between genders.
Supplements were more common among the HIGH (88%) than
LOW (23%) group (p,0.001) (Table 4). The use of supplements
was especially common in the age group 0–2 years (N= 19) in
which 89% used vitamin D supplements. In the oldest age group
(12.1–18.0 years) 63% used vitamin D supplements.
Non-Finnish ethnic background was a risk factor for low 25-
OHD concentration. In this post-hoc cohort 20 of the 100 subjects
had non-Finnish background: non-Finnish ethnicity was more
frequent in the LOW compared to the HIGH group
(p,0.001)(Table 4). In addition, vitamin supplements were used
by only five (25%) of those with non-Finnish background,
compared to 59% of subjects with Finnish background.
Patients with extreme 25-OHD concentrations represented
gastroenterology (30%), endocrinology (31%), nephrology (14%),
eating disorders (6%) and other pediatric subspecialities (19%)
(Figure 3). Patients from gastroenterology and endocrinology were
equally represented in the LOW and HIGH groups. Notably 11 of
14 subjects with a renal disorder belonged to the HIGH group and
six of them had increased P-Crea. Supranormal creatinine levels
suggest that in these subjects high S-25-OHD values may partly
reflect impaired renal vitamin D hydroxylation and in such a case
suggest poor rather than good vitamin D status despite high S-25-
OHD. Patients with eating disorders were prevalent in LOW
group.
None of the patients had hypercalcemia; P-Ca and P-Pi levels
were similar in the LOW and HIGH groups. PTH levels were
significantly higher in the LOW than in the HIGH group, even
when the subjects with increased S-Cr were omitted from the
analysis (77.7 vs. 36.2, p = 0.002).
Discussion
Our study involving more than 1300 children and adolescents
with a chronic illness shows an alarmingly high prevalence of
vitamin D deficiency among patients followed in a large pediatric
centre. Age determined most of the variation in serum 25-OHD
concentration: the prevalence of vitamin D deficiency was highest
among adolescents and lowest in infants. In addition to older age,
lack of vitamin D supplementation and non-Finnish ethnic
background were risk factors for poor vitamin D status. We
observed significant seasonal variation in S-25-OHD concentra-
tion, still 28% of the outpatients remained vitamin D deficient or
insufficient during the summer.
Almost 80% of infants had S-25-OHD concentration above
50 nmol/L. Our finding is consistent with a prospective study in
which most infants aged 14 months had sufficient vitamin D status
[18]. This implies that during the first two years of life children
usually receive adequate amount of vitamin D from diet and
supplements. Families of young children are compliant with
vitamin D supplementation, but the use of supplementation
decreases while children grow older [19]. Despite chronic illnesses,
the children under 6 years of age still had a mean concentration of
S-25-OHD above 60 nmol/L and the prevalence of vitamin D
deficiency ( = S-25-OHD below 37.5 nmol/L) was only approx-
imately 10%. The post-hoc analysis reinforced that vitamin D
status in infants is better than in older children and adolescents.
Interestingly, no seasonal variation in S-25-OHD concentration
in children under 6 years was noted, implying that compared to
dietary supply the effect of sunlight exposure is very limited in
younger Finnish children with a chronic illness. Vitamin D
insufficiency has been under discussion in Finland during the last
few years, and this may have improved parents’ awareness of the
importance of vitamin D supplementation. Furthermore, liquid
dairy products and spreads are currently fortified with vitamin D
in Finland [20]. On 2010 the National Nutrition Council
recommended an increase to the fortification level in liquid dairy
products from 0.5 mg to 1 mg per 100 ml and in spreads from
10 mg to 20 mg per 100 g which were rapidly adopted by many
dairy companies. These could explain the slight increase in S-25-
OHD concentrations in 2010 in all age groups.
Table 3. Variation in mean serum 25-hydroxyvitamin D
concentration (nmol/L) in each age group according to
season*.
Age group (y) N Winter Spring Summer Autumn P{
0–2.0 129 70 75 80 71 0.518
2.1–6.0 185 63 62 73 63 0.175
6.1–10.0 229 53 50 67 58 ,0.001
10.1–15.0 473 45 46 57 52 ,0.001
15.1–18.0 319 44 42 57 49 ,0.001
Total 1335 51 51 63 55 ,0.001
*winter =December to February, spring =March to May, summer = June to
August, autumn=September to November.
{Analysis of covariance (ANCOVA) adjusted for calendar year.
doi:10.1371/journal.pone.0060856.t003
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In older age groups the mean S-25-OHD was consistently below
50 nmol/L and the prevalence of vitamin D deficiency was almost
four times higher than in younger age groups. Similar observations
have been reported in healthy children [21,22], but to our
knowledge not in chronically ill patients. The prevalence of
deficiency is in accordance with our finding in apparently healthy
children and adolescents, of whom 39% suffered from deficiency
during winter and spring [13]. Puberty is a critical period in bone
development [23,24] and vitamin D deficiency or even milder
insufficiency may lead to increased risk of fractures and
osteoporosis during childhood and adolescence [11,24] but also
later in adulthood. Some have described a frequent vitamin D
insufficiency in pediatric outpatients [25,26], but these have
included rather small number of subjects. A report from NHANES
demonstrated that vitamin D deficiency was associated with
several cardiovascular risk factors in a pediatric cohort [22]. It is
known that chronic illness in children may associate with delayed
or impaired growth and pubertal development, but other,
secondary health concerns such as metabolic syndrome [27] still
remain inadequately characterized. Thus, despite careful moni-
toring of the disease, more attention should be paid on nutritional
status which has a vast effect on well-being. Adolescents are likely
to require higher intake of vitamin D to ensure sufficient vitamin D
status. Although pediatric recommendations for children with
chronic illness regarding the optimal S-25-OHD level are lacking
Figure 2. Correlation between fP-PTH (ng/L) and S-25-OHD (nmol/L) in children under and over 10 years. Cases with PTH.73 ng/L are
excluded. Pearson correlation coefficients were 20.249 (p,0.001) and 20.163 (p = 0.001) for children under and over 10 years, respectively.
doi:10.1371/journal.pone.0060856.g002
Table 4. Characteristics of the 100 patients in the LOW and
HIGH vitamin D groups. The values are given as mean (SD).
LOW HIGH P**
N 50 50
S-25-OHD (nmol/L) 15.3 (4.1) 119 (16.9) ,0.001
Females (%) 46 56 0.689{
Non-Finnish ethnicity
(%)
36.0 4.0 ,0.001{
Age (years) 13.7 (3.5) 5.9 (5.5) ,0.001
Height (cm) 155.0 (23.0) 102.7 (35.1) ,0.001
Height Z-score 20.4 (1.6) 21.5 (1.8) 0.002
Weight (kg) 48.3 (24.0) 19.5 (15.5) ,0.001
Height-adjusted weight
(%)
+4.7 (28.4) 24.1 (14.0) 0.054
BMI (kg/m2) 19.2 (5.7) 16.0 (2.4) ,0.001
BMI Z-score 20.42 (1.89) 20.80 (1.55) 0.268
Use of vitamin D (%) 22.9 87.5 ,0.001{
**Independent T-test.
{Pearson Chi- Square.
doi:10.1371/journal.pone.0060856.t004
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patients with chronic illness may benefit from S-25-OHD
concentrations above 80 nmol/L, as recommended by the
Endocrine Society expert panel to attain multiple benefits [10].
Children and adolescents aged from 6 to 18 years showed
significant seasonal variation in S-25-OHD concentration. Sum-
mer values were on average 13 nmol/L higher compared to
winter values. Seasonal variation in vitamin D status has been
reported in healthy children [28,29]. Nevertheless, more than
every fourth patient had subnormal vitamin D status during the
summer months: 11% had vitamin D deficiency and 17% had
vitamin D insufficiency. Helsinki is located at 60#N and therefore
sun exposure from October to April is minimal and during this
period vitamin D production in the skin is limited [30]. Children
with chronic illness are less likely to spend time outside than
healthy children and their sunlight exposure may be limited even
in the summer.
Some studies have described optimal vitamin D status by
maximal suppression on PTH [31], but PTH may not plateau at
all [32]. We found an inverse correlation between PTH and S-25-
OHD, but no plateau. The correlation was stronger in younger
subjects than in adolescents older than 10 years of age. This
suggests that during rapid pubertal growth PTH secretion is
regulated by multiple factors besides S-25-OHD as described
earlier [3]. Taken together this and the intermittent nature of
PTH, it seems that PTH is not an outcome to base the definition
of optimal vitamin D status in pediatric population.
Special concern should be paid to patients with non-Finnish
ethnic background: in the subgroup analysis they were more likely
to have extremely low 25-OHD concentrations and less likely to
use of vitamin D supplements than native Finns. People with non-
Finnish background usually have darker skin pigmentation and
they require longer sunlight exposure for vitamin D synthesis [34].
Furthermore, the intake of fish, milk and milk products is very low
in immigrant populations around Europe [35], thus the current
fortification policy, involving mainly dairy products, may not be
effective to them. Since the overall proportion of children and
adolescents with non-Finnish background in the hospital area is
very low, ethnic factors do not explain the overall poor vitamin D
status in our study.
According to guidelines of the Finnish National Nutrition
Council (2011), which were revised after our data collection
period, children and adolescent under 18 years of age should
receive daily supplementation of vitamin D (7.5–10 mg) through-
out the year regardless of diet. Based on our findings these changes
are timely: the use of vitamin D supplements prevents deficiency.
It is surprising that the 50 highest 25-OHD concentrations
measured in a large university hospital out-patient clinic over a 4-
year-period, ranged only from 103 to 168 nmol/L This suggests
that overall there is a great need to change the pediatric practices
when using vitamin D supplements in patients with an underlying
chronic illness. The levels are far from toxic and if only 12% of the
measured values exceed 80 nmol/L it is clear that the vast
majority of children with a chronic illness have suboptimal vitamin
D status. All reports of vitamin D toxicity showing evidence of
hypercalcemia involve serum 25-OHD concentrations significant-
ly above 200 nmol/L and require daily intake of $1000 mg (40
000 IU) [7]. Thus, regular and more liberal use of vitamin D
supplements within upper level of intake [9] should be encourages
in pediatric patients. Furthermore, the current recommendations
are intended only for healthy individuals. In the case of chronically
ill children vitamin D supplementation should be considered
individually and S-25-OHD concentration should be measured at
least when diagnosis of chronic illness is made and during
exacerbations.
Post-hoc analysis showed that patients with eating disorders are
more likely to have low 25-OHD concentration while high values
are common in renal disease. Previously chronic illnesses, such as
inflammatory bowel disease [36], type 1 diabetes [37], juvenile
Figure 3. Underlying chronic illnesses in the LOW and HIGH vitamin D status groups.
doi:10.1371/journal.pone.0060856.g003
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idiopathic arthritis [38] and solid organ [39] and bone marrow
transplantation [40] in children are associated with vitamin D
deficiency. On the other hand, vitamin D deficiency or in-
sufficiency may be a consequence of a chronic illness that affects
vitamin D metabolism or absorption, such as biliary atresia and
autoimmune hepatitis [41], chronic kidney disease [42], in-
flammatory bowel disease [36], or cancer [43]. Due to cross-
sectional study design, we were not able to evaluate causality or
the consequences of our findings.
Our study has several limitations. The group of chronically ill
children in this study does not include all chronically ill patients
visiting the Children’s Hospital, Helsinki. This register-based study
included all pediatric outpatients who had S-25-OHD measured
between 2007 and 2010. Sampling was based on the judgment of
individual clinicians. Due to high prevalence of vitamin D
deficiency in Finland assessment of vitamin D status has become
an established part of the clinical follow-up and therefore sampling
bias is unlikely. Based on our large sample size, the study
represents and evaluates reliably the vitamin D status in
chronically ill outpatient children in Finland. The retrospective
hospital register-based approach prevented us from collecting all
relevant information, including dosing of and compliance with
vitamin D supplements, dietary intake of vitamin D and
confounding factors such as inflammatory status. The post-hoc
analysis was limited and due to the large number of various
underlying chronic illnesses in the study population and the
relatively small sample size in post-hoc analysis we were not able to
demonstrate significant differences in vitamin D status between the
diagnostic groups.
We conclude that vitamin D deficiency is alarmingly prevalent
in pediatric patients, especially in adolescents, with a chronic
illness. Despite marked seasonal variation, S-25-OHD concentra-
tions are low throughout the year and even in summer 27% of
pediatric outpatients remain vitamin D deficient or insufficient.
Predisposing factors for vitamin D deficiency include older age,
non-Finnish background, lack of vitamin D supplementation and
winter. Clinicians responsible for the follow-up of pediatric
patients should be aware of the problem and actively monitor
vitamin D status of their patients to ensure vitamin D sufficiency.
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